Back
Nektar Therapeutics Stock Price Chart
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now
Sell
32
NKTR
Nektar Therapeutics
Last Price:
$37.34
Seasonality Move:
1.64%
7 Day Trial
ALL ACCESS PASS
$
7
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Nektar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.78 | Buy |
| 20-day SMA: | 38.47 | Sell |
| 50-day SMA: | 47.49 | Sell |
| 200-day SMA: | 35.24 | Buy |
| 8-day EMA: | 14.38 | Buy |
| 20-day EMA: | 6.59 | Buy |
| 50-day EMA: | 2.79 | Buy |
| 200-day EMA: | 0.72 | Buy |
Nektar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.15 | Buy |
| Relative Strength Index (14 RSI): | 41.15 | Sell |
| Chaikin Money Flow: | 825387 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.21 - 42.73) | Sell |
| Bollinger Bands (100): | (43.48 - 60.88) | Sell |
Nektar Therapeutics Technical Analysis
| Jan 16 | Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 16 | 20 | 21 | 22 | 23 | 26 | 27 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Nektar Therapeutics Stock
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 37.33 while NKTR 8-day simple moving average is 36.78, which is a Buy signal.
-
The stock price of NKTR is 37.33 while Nektar Therapeutics 20-day SMA is 38.47, which makes it a Sell.
-
Nektar Therapeutics 50-day simple moving average is 47.49 while NKTR share price is 37.33, making it a Sell technically.
-
NKTR stock price is 37.33 and Nektar Therapeutics 200-day simple moving average is 35.24, creating a Buy signal.
NKTR Technical Analysis vs Fundamental Analysis
Sell
32
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a SellThe current Nektar Therapeutics [NKTR] share price is $37.33. The Score for NKTR is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Nektar Therapeutics Stock Info
Market Cap:
645.8M
Price in USD:
37.33
Share Volume:
995.5K
Nektar Therapeutics 52-Week Range
52-Week High:
66.92
52-Week Low:
6.48
Sell
32
Nektar Therapeutics (NKTR)
is a Sell
Nektar Therapeutics Share Price Forecast
-
What is the Nektar Therapeutics stock price today?The Nektar Therapeutics stock price is 37.33 USD today.
-
Will NKTR stock go up or go down?Nektar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Nektar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nektar Therapeutics is overvalued.
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 37.33 while NKTR 8-day exponential moving average is 14.38, which is a Buy signal.
-
The stock price of NKTR is 37.33 while Nektar Therapeutics 20-day EMA is 6.59, which makes it a Buy.
-
Nektar Therapeutics 50-day exponential moving average is 2.79 while NKTR share price is 37.33, making it a Buy technically.
-
NKTR stock price is 37.33 and Nektar Therapeutics 200-day simple moving average is 0.72, creating a Buy signal.
Fundamental Analysis of Nektar Therapeutics
Is Nektar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.54 per share, and a decrease next year of $2.39 per share.
Technical Analysis of Nektar Therapeutics
Should I short Nektar Therapeutics stock?
-
NKTR Moving Average Covergence Divergence (MACD) indicator is 5.15, suggesting Nektar Therapeutics is a Buy
-
Nektar Therapeutics Relative Strength Index (RSI) is 41.15, which suggest Nektar Therapeutics is oversold
-
The Bollinger Bands (25) for Nektar Therapeutics is (36.21 - 42.73), which suggest Nektar Therapeutics is a Sell
-
The Bollinger Bands (100) for Nektar Therapeutics is (43.48 - 60.88), which suggest Nektar Therapeutics is a Sell
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.